Fabtech Technologies, a pharmaceuticals engineering solutions provider, has filed for an IPO. The IPO will consist of a fresh issue of up to 1.20 crore equity shares, with proceeds used for working capital, acquisitions, and general corporate purposes. The issue will be divided among QIBs, non-institutional bidders, and retail investors.
